SRX Health Solutions Inc. Common Stock (SRXH)

FairStock Score: 15/100 — RISKY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look first for a business I can understand and that earns consistent profits. SRX Health Solutions fails that test. Its description is an AI-driven investment platform, yet the data label it Consumer Defensive/Packaged Foods, and the filed numbers tell a shrinking, loss-making story. In fiscal Q3 2026, the quarter ended 2026-06-30, revenue was $3.4 million and net income was -$4.1 million. For FY2025 ended 2025-09-30, revenue was $6.5 million and the net loss was $45.0 million. Filed revenue in FY2023 was $38.6 million and FY2022 was $54.7 million, so the trend is down, not compounding. Trailing free cash flow is -$2.9 million, and revenue growth is -51.96%. A seven-employee company with no dividend and debt-to-equity of 1.24 offers little margin of safety. The FairStock computed P/E of 0.02, P/B of 0.19, Graham Number of $101.28, and 98.65% margin of safety look spectacular, but they are arithmetic artifacts from an EPS figure of $62.19 and book values; the actual operations are losing money. Piotroski F-Score 3/9 and FairStock Score 15/100 confirm weakness. FairStock calls it a turnaround, based on a loss in the latest year after earlier profits. Turnarounds can pay, but only when the business has durable competitive advantages and improving economics. Here I see no clear moat, falling revenue, negative cash flow, and erratic per-share figures. The price may be low, but value is not proven. I would want several quarters of positive cash flow and stable revenue before calling it a bargain.

In plain English: SRX Health Solutions is a small company described as an AI-driven investment platform, though its business labels are mixed. Its recent filed results show it is losing money, revenue has been shrinking, and cash flow is negative. The stock price looks very cheap against some calculated numbers, but those numbers are based on accounting data that does not match the actual losses, so the cheapness is uncertain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q3 2026 10-Q (period ended 2026-06-30) · fiscal Q2 2026 10-Q (period ended 2026-03-31) · fiscal Q1 2026 10-Q (period ended 2025-12-31) · fiscal Q3 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-09-30) · FY2023 10-K (period ended 2023-12-31) · FY2022 10-K (period ended 2022-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer